Citi Pharma schedules board meeting for October 30, 2026
Board MeetingCiti Pharma Limited will hold a board meeting on October 30, 2026, to consider and approve its unaudited unconsolidated and consolidated condensed interim financial statements for the quarter ended September 30, 2026. A closed period applies from October 24 through October 30, 2026, inclusive.
Key Findings
- Board meeting scheduled for October 30, 2026, at 4:00 p.m. at the company’s head office in Lahore.
- The board will consider interim financial statements for the quarter ended September 30, 2026.
- The closed period runs from October 24 to October 30, 2026, inclusive; directors, the CEO, and executives are prohibited from dealing in company shares during this period.
Meeting Details
Meeting time
30/10/2026, 4:00 PM
Agenda
Financial results
Financial Period
Quarter ended September 30, 2026
Location
Head office, 588, Q-Block, Johar Town, Lahore
Closed period from
24/10/2026
Closed period to
30/10/2026
⚡
Highlights summarize the key points from the company's official PSX filing. View the original filing for the complete details before making financial decisions.



